House
File
2326
-
Introduced
HOUSE
FILE
2326
BY
KRESSIG
,
BEARINGER
,
FORBES
,
BROWN-POWERS
,
MEYER
,
STAED
,
COHOON
,
KURTH
,
LENSING
,
ABDUL-SAMAD
,
STECKMAN
,
WOLFE
,
BENNETT
,
MASCHER
,
ISENHART
,
KEARNS
,
OURTH
,
NIELSEN
,
WESSEL-KROESCHELL
,
KACENA
,
GASKILL
,
OLSON
,
HUNTER
,
ANDERSON
,
McCONKEY
,
BRECKENRIDGE
,
R.
SMITH
,
WINCKLER
,
T.
TAYLOR
,
and
JACOBY
A
BILL
FOR
An
Act
relating
to
the
medical
cannabidiol
Act,
by
amending
1
the
definition
of
medical
cannabidiol
and
altering
the
2
composition
and
duties
of
the
medical
cannabidiol
board.
3
BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
4
TLSB
5877YH
(3)
87
ss/rh
H.F.
2326
Section
1.
Section
124E.2,
subsection
6,
Code
2018,
is
1
amended
by
striking
the
subsection
and
inserting
in
lieu
2
thereof
the
following:
3
6.
“Medical
cannabidiol”
means
any
species
of
the
genus
4
cannabis
plant,
or
any
mixture
or
preparation
of
them,
5
including
whole
plant
extracts
and
resins.
6
Sec.
2.
Section
124E.5,
subsection
1,
paragraph
a,
Code
7
2018,
is
amended
to
read
as
follows:
8
a.
A
medical
cannabidiol
board
is
created
consisting
of
9
eight
practitioners
representing
the
fields
of
neurology,
pain
10
management,
gastroenterology,
oncology,
psychiatry,
pediatrics,
11
family
medicine,
and
pharmacy,
and
one
representative
from
law
12
enforcement
,
and
a
patient
or
primary
caregiver
in
possession
13
of
a
valid
medical
cannabidiol
registration
card
issued
14
pursuant
to
this
chapter
.
15
Sec.
3.
Section
124E.5,
subsection
2,
Code
2018,
is
amended
16
to
read
as
follows:
17
2.
The
medical
cannabidiol
board
shall
convene
at
least
18
twice
but
no
more
than
four
times
per
year.
19
Sec.
4.
Section
124E.5,
subsection
3,
Code
2018,
is
amended
20
by
adding
the
following
new
paragraph:
21
NEW
PARAGRAPH
.
f.
Adding
by
rule
medical
conditions,
22
medical
treatments,
or
debilitating
diseases
to
the
list
of
23
debilitating
medical
conditions
for
which
the
medical
use
of
24
cannabidiol
would
be
medically
beneficial
under
this
chapter
if
25
the
medical
use
of
cannabidiol
is
approved
for
the
treatment
of
26
such
a
medical
condition,
medical
treatment,
or
debilitating
27
disease
in
at
least
two
neighboring
states.
28
EXPLANATION
29
The
inclusion
of
this
explanation
does
not
constitute
agreement
with
30
the
explanation’s
substance
by
the
members
of
the
general
assembly.
31
This
bill
relates
to
the
medical
cannabidiol
Act.
32
The
bill
alters
the
definition
of
medical
cannabidiol
33
by
providing
that
“medical
cannabidiol”
means
any
species
34
of
the
genus
cannabis
plant,
or
any
mixture
or
preparation
35
-1-
LSB
5877YH
(3)
87
ss/rh
1/
2
H.F.
2326
thereof,
including
whole
plant
extracts
and
resins.
The
bill
1
removes
the
requirement
in
the
current
definition
that
medical
2
cannabidiol
have
a
tetrahydrocannabinol
(THC)
level
of
no
more
3
than
3
percent.
The
bill
adds
to
the
members
of
the
medical
4
cannabidiol
board
a
patient
or
primary
caregiver
with
a
valid
5
medical
cannabidiol
registration
card
issued
under
Code
chapter
6
124E
(medical
cannabidiol
Act),
and
removes
the
requirement
7
that
the
medical
cannabidiol
board
meet
no
more
than
four
times
8
per
year.
9
The
bill
allows
the
medical
cannabidiol
board
to
add
to
the
10
list
of
debilitating
medical
conditions
for
which
a
medical
11
cannabidiol
registration
card
may
be
issued
if
the
treatment
by
12
medical
cannabidiol
of
such
a
debilitating
medical
condition
is
13
approved
by
at
least
two
neighboring
states.
14
-2-
LSB
5877YH
(3)
87
ss/rh
2/
2